Announcements Trials
Browse Landscape

Phase

Phase 2 147Phase NA 49Phase 3 46Phase 1/2 25Phase 2/3 20Phase 1 19Phase 4 5Phase EARLY_PHASE1 3

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Gynecologic 2Lymphoid 1Head & Neck 1

Conditions

Successful Conversion Rate of Operation 1Rectal Neoplasms 1Pancreatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 11Oxaliplatin 9Fluorouracil 9Leucovorin 7Irinotecan 7Gemcitabine 7Nivolumab 6Biopsy 6Bevacizumab 6pembrolizumab 5lenvatinib 5Specimen Handling 5Radiosurgery 5Cisplatin 5Capecitabine 5X-Rays 4Radiation 4Proflavine 4Oncolytic Virotherapy 4Cyclophosphamide 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4sodium thiosulfate 3gallium 68 PSMA-11 3folfirinox 3Surgical Procedures, Operative 3Paclitaxel 3Omeprazole 3Ketamine 3Immune Checkpoint Inhibitors 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Drug Therapy × Gastrointestinal × Clear all
NCT03594630 2026-05-20

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Recruiting
120 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06326736 2024-03-22

Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer

Jinling Hospital, China

Phase EARLY_PHASE1 Recruiting
12 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03822130 2019-02-20

Intra-arterial Infusion Chemotherapy Combined With Sodium Bicarbonate for Unresectable Gastric Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase EARLY_PHASE1 Unknown
150 enrolled
Gastrointestinal

Successful Conversion Rate of Operation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡